- Tytuł:
- Can We Use Blood Biomarkers as Entry Criteria and for Monitoring Drug Treatment Effects in Clinical Trials? A Report from the EU/US CTAD Task Force
- Autorzy:
- Źródło:
- The Journal of Prevention of Alzheimer's Disease. 10(3):418-425
Czasopismo naukowe